← Back to Intelligence Desk
Channel: Neuralink
Neuralink BioTech & Infra tech investor
Neuralink: 'Blindsight implant achieves functional visual cortex mapping in early trials'
N
Neuralink Dispatch
Analysis & Special Reports
• 5 min read
Core Premise & Signal
"High-density 1,024-channel microelectrode array bypasses damaged optic nerve to stimulate visual cortex directly."
Original Intelligence Source
@neuralink
Neuralink Blindsight updates: following FDA Breakthrough Device designation, preliminary cortex stimulation mapping shows localized visual phosphenes in primary visual cortex (V1) bypassing optic nerve damage. Source: @neuralink
Intel Disclaimer: The analysis above is produced by MacroHard Hub for informational and analytical purposes. Past trends in Tesla, SpaceX, xAI, or associated equities do not guarantee future returns.